Sector
PharmaceuticalsOpen
₹9.02Prev. Close
₹9.02Turnover(Lac.)
₹0.05Day's High
₹9.02Day's Low
₹952 Week's High
₹13.4752 Week's Low
₹6.7Book Value
₹0.87Face Value
₹2Mkt Cap (₹ Cr.)
9.23P/E
90EPS
0.1Divi. Yield
019 May 2025
12:00 AM
Board Meeting
Agenda : Audited Result
31 Jul 2024
12:00 AM
AGM
Announcement Date: 31 Jul, 2024
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 2.05 | 2.05 | 10.25 | 10.25 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | -1.25 | -1.3 | -9.46 | -8.95 |
Net Worth | 0.8 | 0.75 | 0.78 | 1.3 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 1.03 | 1.94 | 1.03 | 1.01 |
yoy growth (%) | -46.89 | 88.46 | 1.84 | -19.64 |
Raw materials | -0.68 | -1.3 | -0.56 | -0.72 |
As % of sales | 65.93 | 66.92 | 55.04 | 71.82 |
Employee costs | -0.24 | -0.25 | -0.22 | -0.26 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | -0.95 | 0.11 | -2.27 | -0.48 |
Depreciation | 0 | -0.01 | 0 | -0.01 |
Tax paid | 0.01 | -0.03 | 0 | 0 |
Working capital | -0.87 | 1.25 | 0.09 | -0.13 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -46.89 | 88.46 | 1.84 | -19.64 |
Op profit growth | -791.35 | -105.78 | 404.59 | 278.8 |
EBIT growth | -860.9 | -105.49 | 376.04 | 255.53 |
Net profit growth | -1,262.13 | -103.55 | 362.89 | -76.45 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,669.3 | 93.52 | 4,00,520.99 | 2,000.46 | 0.96 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,613.75 | 79.48 | 1,75,574.28 | 667 | 0.45 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,512.75 | 25.39 | 1,22,186 | 1,485.4 | 1.06 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,321.2 | 20.61 | 1,10,263.53 | 1,200.7 | 0.61 | 5,546.3 | 345.76 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,225.7 | 57.29 | 1,09,167.44 | 474 | 0.99 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
J.V.R. Mohan Raju
Non Executive Director
J Uma
Independent Director
Reji Abraham
Director & CFO
Jaison George
H No 8-2-269/S PlotNo 31 RdNo2,
Sagar Co-Op Hous Banjara Hills,
Telangana - 500034
Tel: 91-40-23555161/23555181
Website: http://www.hindustanbiosciences.in
Email: [email protected], pharma.hindustanbio@
H No 8-2-269/S,
Plot No 31 Rd No 2, Banjara Hills,
Hyderabad - 500034
Tel: -
Website: -
Email: -
Summary
Hindustan Bio Science Ltd (Formerly known Hindustan Softel Ltd) was incorporated as Public Limited Company on December 16, 1991. The Company engaged in the manufacturing and sale of pharmaceutical pro...
Read More
Reports by Hindustan Bio Sciences Ltd
What is the Hindustan Bio Sciences Ltd share price today?
What is the Market Cap of Hindustan Bio Sciences Ltd?
What is the PE and PB ratio of Hindustan Bio Sciences Ltd?
What is the 52 Week High and Low of Hindustan Bio Sciences Ltd?
What is the CAGR of Hindustan Bio Sciences Ltd?
What is the shareholding pattern of Hindustan Bio Sciences Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.